MINNEAPOLIS - May 19, 2014 - Medtronic, Inc. (NYSE: MDT) announced the appointment of Brad Lerman as senior vice president, general counsel and corporate secretary effective May 27, 2014. In this role, Lerman will report to Medtronic Chairman and CEO, Omar Ishrak.

As senior vice president, general counsel and corporate secretary, Lerman will lead the global legal function across the company. In addition, he will direct Medtronic's government affairs department and serve as a member of Medtronic's executive committee.

"I am pleased to name Brad to this important executive position at Medtronic," said Ishrak. "He brings strong leadership skills, litigation expertise and business acumen, which will serve him well as he takes on this role leading the global legal and government affairs teams."

Lerman brings 25 years of legal experience in the public and private sectors and joins Medtronic from the Federal National Mortgage Association (Fannie Mae) where he served as executive vice president, general counsel and corporate secretary.  Prior to this role, Lerman served as senior vice president, associate general counsel and chief litigation counsel for Pfizer.  Earlier in his career, Lerman spent 20 years as an attorney in private practice and as a federal prosecutor for the U.S. Department of Justice.

Lerman received his juris doctor from Harvard Law School, and a bachelor's degree in economics from Yale University.  He was also an adjunct professor at Northwestern University School of Law.

ABOUT MEDTRONIC
Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health and extending life for millions of people around the world.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

- end -

Contacts:
Cindy Resman
Public Relations
+1-763-505-0291

Jeff Warren
Investor Relations
+1-763-505-2696